PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2022.03262023291163-164Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”Yuanbin Liu, Mingkai Chenhttp://e-cmh.org/upload/pdf/cmh-2022-0326.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0326, http://e-cmh.org/upload/pdf/cmh-2022-0326.pdf
Clinical and Molecular Hepatology10.3350/cmh.2022.03812023291171-172Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”Seung Min Lee, Dae Won Junhttp://e-cmh.org/upload/pdf/cmh-2022-0381.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0381, http://e-cmh.org/upload/pdf/cmh-2022-0381.pdf
Clinical and Molecular Hepatology10.3350/cmh.2022.00682022284827-840Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathwaysSeung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kimhttp://e-cmh.org/upload/pdf/cmh-2022-0068.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0068, http://e-cmh.org/upload/pdf/cmh-2022-0068.pdf
10.21203/rs.3.rs-993103/v12021TMAO Stimulate Inflammation and Lipid Accumulation via NF-κB Signaling Pathway in Nonalcoholic Fatty Liver Diseasezhijun chen, Jiale Zhang, Qian Cheng, Xiangsheng Cai, RuiTian Xie, TeBin Liu, XiaoDong Wang, JieNa Caihttps://www.researchsquare.com/article/rs-993103/v1, https://www.researchsquare.com/article/rs-993103/v1.html
Frontiers in Pharmacology10.3389/fphar.2020.605064202111Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling PathwayYing-Li Liu, Qiu-Zan Zhang, Yan-Rong Wang, Li-Na Fu, Jing-Shu Han, Jing Zhang, Bang-Mao Wanghttps://www.frontiersin.org/articles/10.3389/fphar.2020.605064/full
Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment10.5772/intechopen.711612018Noninvasive Evaluation of Fibrosis and Steatosis in Nonalcoholic Fatty Liver Disease by Elastographic MethodsMonica Lupsor-Platonhttp://www.intechopen.com/download/pdf/58040
Nutrients10.3390/nu14010076202114176Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and ApoptosisJinwang Li, Siyu Xie, Wendi Tenghttps://www.mdpi.com/2072-6643/14/1/76/pdf
Biomedicine & Pharmacotherapy10.1016/j.biopha.2021.1118742021141111874Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathwaysWeixin Zhao, Yixiao Yan, Zhongxiang Xiao, Meihong Wang, Mingjiang Xu, Zhe Wang, Yi Wang, Zaishou Zhuang, Daona Yang, Gaozhi Chen, Guang Lianghttps://api.elsevier.com/content/article/PII:S0753332221006569?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0753332221006569?httpAccept=text/plain
Antioxidants10.3390/antiox100303662021103366Protective Effect of Oligonol on Dimethylnitrosamine-Induced Liver Fibrosis in Rats via the JNK/NF-κB and PI3K/Akt/Nrf2 Signaling PathwaysChangyong Lee, Jeonghyeon Bak, Sik Yoon, Jeon-Ok Moonhttps://www.mdpi.com/2076-3921/10/3/366/pdf
Food & Function10.1039/d1fo00310k202112104591-4605A polysaccharide of PFP-1 from Pleurotus geesteranus attenuates alcoholic liver diseases via Nrf2 and NF-κB signaling pathwaysXinling Song, Wenxue Sun, Weijun Cui, Le Jia, Jianjun Zhanghttp://pubs.rsc.org/en/content/articlepdf/2021/FO/D1FO00310K